全文获取类型
收费全文 | 2717374篇 |
免费 | 190911篇 |
国内免费 | 7967篇 |
专业分类
耳鼻咽喉 | 36164篇 |
儿科学 | 88948篇 |
妇产科学 | 74975篇 |
基础医学 | 381222篇 |
口腔科学 | 74725篇 |
临床医学 | 243687篇 |
内科学 | 545567篇 |
皮肤病学 | 66602篇 |
神经病学 | 224408篇 |
特种医学 | 102693篇 |
外国民族医学 | 764篇 |
外科学 | 402291篇 |
综合类 | 51187篇 |
现状与发展 | 5篇 |
一般理论 | 1008篇 |
预防医学 | 209027篇 |
眼科学 | 59290篇 |
药学 | 196833篇 |
8篇 | |
中国医学 | 5882篇 |
肿瘤学 | 150966篇 |
出版年
2021年 | 23423篇 |
2019年 | 24032篇 |
2018年 | 33915篇 |
2017年 | 25485篇 |
2016年 | 29061篇 |
2015年 | 32528篇 |
2014年 | 44479篇 |
2013年 | 66133篇 |
2012年 | 89379篇 |
2011年 | 94161篇 |
2010年 | 56216篇 |
2009年 | 53222篇 |
2008年 | 86587篇 |
2007年 | 91741篇 |
2006年 | 92973篇 |
2005年 | 89094篇 |
2004年 | 85248篇 |
2003年 | 82108篇 |
2002年 | 79024篇 |
2001年 | 130817篇 |
2000年 | 133909篇 |
1999年 | 112668篇 |
1998年 | 32020篇 |
1997年 | 28500篇 |
1996年 | 28712篇 |
1995年 | 27827篇 |
1994年 | 25429篇 |
1993年 | 23770篇 |
1992年 | 86260篇 |
1991年 | 82626篇 |
1990年 | 79770篇 |
1989年 | 76940篇 |
1988年 | 70278篇 |
1987年 | 68780篇 |
1986年 | 64301篇 |
1985年 | 61195篇 |
1984年 | 45446篇 |
1983年 | 38392篇 |
1982年 | 22763篇 |
1981年 | 20240篇 |
1979年 | 39464篇 |
1978年 | 27785篇 |
1977年 | 23568篇 |
1976年 | 21807篇 |
1975年 | 23219篇 |
1974年 | 27257篇 |
1973年 | 25891篇 |
1972年 | 24176篇 |
1971年 | 22388篇 |
1970年 | 20609篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
M Vitacca M Paneroni L Bianchi E Clini A Vianello P Ceriana L Barbano B Balbi S Nava 《The European respiratory journal》2006,27(2):343-349
The present study compared four different sites and conditions for the measurement of maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) in 38 spontaneous breathing tracheotomised patients. Of the patients, 28 had chronic obstructive pulmonary disease (COPD). The four different conditions were: 1) through a cuff inflated cannula (condition A); 2) through the mouth with a deflated cannula (condition B); 3) through the mouth with a phonetic uncuffed cannula (condition C); and 4) through the mouth after stoma closure (condition D). Five trials in each condition were performed using a standardised method. The measurement of both MIP and MEP differed significantly depending on the condition of measurement. MIP taken in condition A was significantly higher when compared with conditions B, C and D. MEP in condition A was significantly higher when compared with condition B and D. In condition A the highest frequency of the best measurement of MIP and MEP was observed at the fourth and fifth effort, respectively. The same results were obtained after the selection of only COPD patients. In conclusion, respiratory muscle assessment differs significantly depending on measurement condition. Measurement through inflated cannula tracheotomy yields higher values of both maximal inspiratory and maximal expiratory pressure. 相似文献
42.
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care.
R Erbes K Oettel M Raffenberg H Mauch M Schmidt-Ioanas H Lode 《The European respiratory journal》2006,27(6):1223-1228
Severe tuberculosis (TB) requiring intensive care unit (ICU) care is rare but commonly known to be of markedly bad prognosis. The present study aimed to describe this condition and to determine the mortality rate and risk factors associated with mortality. Patients with confirmed TB admitted to ICU between 1990 and 2001 were retrospectively identified and enrolled. Clinical, radiological and bacteriological data at admission and during hospital stay were recorded. A multivariate analysis was performed to identify the predictive factors for mortality. A total of 58 TB patients (12 females, mean age 48 yrs) admitted to ICU were included. Mean Acute Physiology and Chronic Health Evaluation (APACHE) II score at admission was 13.1+/-5.6 and 22 of 58 (37.9%) patients required mechanical ventilation. The in-hospital mortality was 15 of 58 (25.9%); 13 (22.4%) patients died in the ICU. The mean survival of patients who died was 53.6 days (range 1-229), with 50% of the patients dying within the first 32 days. The factors independently associated with mortality were: acute renal failure, need for mechanical ventilation, chronic pancreatitis, sepsis, acute respiratory distress syndrome, and nosocomial pneumonia. These data indicate a high mortality of patients with tuberculosis requiring intensive care unit care and identifies new independently associated risk factors. 相似文献
43.
44.
45.
TG Berger F Kiesewetter C Maczek N Bauer M Lueftl G Schuler M Simon Jr 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):178-183
Vitiligo and psoriasis are both common skin disorders. However, psoriasis strictly confined to pre-existing vitiligo areas is rare and suggests a causal relationship. We report here on two patients with a strict anatomical colocalization of vitiligo and psoriasis. The histopathological examinations showed typical changes for both diseases together with a dense infiltrate of CD4+ and CD8+ T cells. By immunohistochemistry, intracytoplasmatic granzyme B and tumour necrosis factor alpha (TNF-alpha) were detected within the T-cell population, suggesting the functional activity of these cells and the creation of a local T helper 1 (Th1)-cytokine milieu. Additionally, in one patient we could identify anti-melanocytic T cells by tetramer staining and enzyme-linked immunospot (ELISPOT) analysis. These skin-infiltrating lymphocytes might trigger, by the local production of Th-1 cytokines such as TNF-alpha and interferon-gamma (IFN-gamma), the eruption of psoriatic plaques in patients with a genetic predisposition for psoriasis. 相似文献
46.
Dolores Herreros Mariano García-Arranz Isabel Pascual Damián García-Olmo 《Experimental dermatology》2006,15(6):482-482
Purpose: To evaluate all consecutive patients treated with infliximab for hidradenitis suppurativa (HS).
Patients and methods: Within 1 year, all consecutive patients seen in our department for HS (1) resistant to usual medical therapies (2) which could not be easily cured by surgery (3) not treated with new medication within 2 months before inclusion were treated intravenously with infliximab (5 mg/kg) without corticosteroids premedication. Four infusions were planned (week 0, week 2, week 6 and week 10) before the interruption of therapy and follow-up. Clinical activity of HS and quality of life of the patients were assessed immediately before the first, the third and the fourth infusions of infliximab.
Results: Seven patients were included. Five completed the four infusions. Two patients received only three infusions because of severe side effects. The Sartorius score moderately improved with infliximab (mean score at week 0: 94 ± 39, at week 6: 71 ± 38 and at week 10: 83 ± 48). At week 6, patients judged the efficacy of therapy as marked ( n = 1), moderate ( n = 4) or null ( n = 2). At week 10, five patients were evaluated and judged this efficacy as marked ( n = 2), moderate ( n = 2) or null ( n = 1). The mean Skindex-29 score varied from 22 ± 11 (E: 25 ± 9, S: 13 ± 5, F: 28 ± 12) at week 0 to 18 ± 10 (E: 22 ± 8, S: 12 ± 8, F: 22 ± 12) at week 10.
Conclusion: The efficacy of infliximab in severe HS is partial. More experience is needed before finding a place for infliximab in the therapeutic armamentarium for HS. 相似文献
Patients and methods: Within 1 year, all consecutive patients seen in our department for HS (1) resistant to usual medical therapies (2) which could not be easily cured by surgery (3) not treated with new medication within 2 months before inclusion were treated intravenously with infliximab (5 mg/kg) without corticosteroids premedication. Four infusions were planned (week 0, week 2, week 6 and week 10) before the interruption of therapy and follow-up. Clinical activity of HS and quality of life of the patients were assessed immediately before the first, the third and the fourth infusions of infliximab.
Results: Seven patients were included. Five completed the four infusions. Two patients received only three infusions because of severe side effects. The Sartorius score moderately improved with infliximab (mean score at week 0: 94 ± 39, at week 6: 71 ± 38 and at week 10: 83 ± 48). At week 6, patients judged the efficacy of therapy as marked ( n = 1), moderate ( n = 4) or null ( n = 2). At week 10, five patients were evaluated and judged this efficacy as marked ( n = 2), moderate ( n = 2) or null ( n = 1). The mean Skindex-29 score varied from 22 ± 11 (E: 25 ± 9, S: 13 ± 5, F: 28 ± 12) at week 0 to 18 ± 10 (E: 22 ± 8, S: 12 ± 8, F: 22 ± 12) at week 10.
Conclusion: The efficacy of infliximab in severe HS is partial. More experience is needed before finding a place for infliximab in the therapeutic armamentarium for HS. 相似文献
47.
48.
OLG München 《MedR Medizinrecht》2006,24(7):431-433
Abstrakt 1. Ein nicht ausgefülltes und nicht unterschriebenes Aufkl?rungsformular in der Krankenakte bildet ein Indiz nicht für, sondern
gegen die Durchführung eines Aufkl?rungsgespr?chs.
2. Wenn vor dem ?rztlichen Eingriff überhaupt keine Aufkl?rung erfolgt, genügt für den Beginn der Verj?hrung eines auf eine
Aufkl?rungspflichtverletzung gestützten Anspruchs die Kenntnis vom Eintritt schwerwiegender Komplikationen. Nicht erforderlich
ist das Wissen, dass sich ein typisches Risiko des Eingriffs verwirklicht hat. 相似文献
49.
50.
A M Carella 《Leukemia》2003,17(6):1199-1200